Multiple sclerosis is a chronic immune-mediated demyelinating disease of the CNS. Its aetiology is thought to involve both a complex genetic component, in which multiple susceptibility genes are important, and several environmental factors [1] [2] [3] [4] . Multiple sclerosis is characterized pathologically by inflammation, demyelination with partial restoration of myelin, axonal and neuronal damage, and glial scarring 5, 6 . The pathogenetic mechanisms leading to these abnormalities are largely unclear.
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As disseminated focal demyelinating lesions in the white matter are the classical hallmark of multiple sclerosis, the disease has long been considered a typical white matter disease. Nevertheless, early histological reports noted that grey matter is also affected and that grey matter damage and cell loss may underlie some of the permanent neurological dysfunction. In 1916, in a comprehensive overview of the histology of disseminated sclerosis, James W. Dawson wrote: "…when an area [of demyelination] is confined to the cortex, the changes are, as a rule, not nearly so marked…" 7 , referring to the striking lack of glial proliferation and cellular paucity (an indicator that inflammation is absent) in grey matter lesions. Dawson also wondered: "Is then, the process that attacks the cortex different in its nature and origin from that which affects the rest of the central nervous system?" 7 . This tantalizing question remains highly relevant today.
There was little post-mortem tissue research investigating grey matter pathology in multiple sclerosis until 1962, when the interest in grey matter lesions in multiple sclerosis was rekindled by a seminal histopathology study 8 that reported that 26% of multiple sclerosis lesions were located in or around the cortical and subcortical grey matter. However, it would become apparent that this was a gross underestimation of actual grey matter damage. It was another four decades before advances in imaging techniques 9, 10 , supported by immunohistochemical observations and investigations in animal models, renewed the interest in grey matter pathology in multiple sclerosis, and began to reveal its high prevalence and to uncover the detailed cellular pathology of grey matter demyelination [11] [12] [13] . Despite the extensive pathological characterization and imaging evidence of grey matter lesions in multiple sclerosis (FIG. 1) , the causes of grey matter damage and its relationship to white matter lesions remain unclear. This Review aims to provide an overview of existing theories regarding grey matter damage in multiple sclerosis, answering -from a histological, immunological and neuroimaging point of view -some of the most pertinent questions regarding its pathogenesis.
Are white and grey matter damage linked?
Since the first demonstration that the cortex is not spared by multiple sclerosis, it has remained unresolved whether cortical tissue damage is secondary to white matter pathology -that is, whether cortical damage occurs via retrograde degeneration -or is a primary pathological process. Grey matter lesions are usually characterized by a relative lack of parenchymal lymphocyte infiltration, deposition of antibody and complement proteins, and blood-brain barrier disruption when compared with white matter
Radiologically isolated syndrome
A syndrome present in a patient who has radiological evidence of an inflammatory demyelinating disease of the CNS but no clinical signs or symptoms of such disease. lesions 12, 14, 15 . In post-mortem samples taken from individuals in the advanced stages of multiple sclerosis, high numbers of immune cells were only detected in type 1 grey matter lesions (FIG. 1a) ; all other grey matter lesions were categorized as relatively 'non-inflammatory' [11] [12] [13] . Moreover, according to post-mortem studies, neuronal loss occurs within both grey matter demyelinated lesions and normal-appearing grey matter 12, 16, 17 , suggesting that neuronal loss might occur independently from grey matter demyelination.
These findings imply that grey matter damage might be a result of non-inflammatory processes or local inflammation that have occurred within the grey matter, or a consequence of white matter lesions that are themselves caused by inflammation.
Evidence that links grey and white matter damage. Consistent with the idea that white matter damage may drive grey matter damage, several MRI studies have reported a significant correlation between white matter damage and grey matter atrophy in conditions other than multiple sclerosis 18 . For example, advanced postprocessing analyses showed a reduction of cortical grey matter volume and thinning of the primary motor cortex in patients with spinal cord injury, suggesting that distant axonal transection can lead to significant cortical atrophy via retrograde degeneration 18 . It has been suggested that the characteristic pattern of white matter pathology in multiple sclerosis could lead to selective retrograde injury to frontal, temporal and motor cortical areas, which would partially explain some of the post-mortem patterns of grey matter damage that have been observed 19 . Indeed, the corticospinal tract, which contains fibre connections to the precentral gyrus, and the frontal periventricular white matter, which consists of efferent and afferent fibres to frontal and superior temporal lobes, are common sites of white matter lesions in multiple sclerosis 20 . Moreover, axonal damage in active white matter lesions (that is, those that are gadolinium-enhanced in contrast MRI) could lead indirectly to anterograde and retrograde degeneration (FIG. 2) of axons running within the thalamus and basal ganglia. Axon loss might also contribute to demyelination and/or Wallerian degeneration by reducing local metabolic activity 21, 22 . A correlation between white matter lesion load and thalamic atrophy was observed in patients with clinically isolated syndrome 23 and early relapsing-remitting multiple sclerosis (RRMS) 24 . More generally, the assumption that white matter lesions and grey matter atrophy are linked is supported by several cross-sectional MRI studies showing significant correlations between the total grey matter volume and the total white matter volume in T1-and T2-weighted lesions [25] [26] [27] [28] . Moreover, a sensitive regional analysis revealed a correlation between regional cortical grey matter loss and white matter lesion volume in the corresponding or adjacent lobes in patients with progressive multiple sclerosis 29 , although the location and extent of grey matter lesions were not studied. Finally, several longitudinal MRI studies [30] [31] [32] indicate an association between accumulation of white matter lesion volumes and grey matter volume loss in the frontal and parietal cortex of patients with RRMS. In addition, white matter lesion volume correlated with ventricular enlargement 32 , focal white matter damage in the optic radiations (FIG. 3a) and upstream grey matter atrophy of the lateral geniculate nucleus and visual cortex in patients with RRMS 33 .
Evidence for independent grey matter damage. An alternative but equally important theory suggests that white matter and grey matter demyelination are two, at least partly, independent phenomena and that neuronal loss is not caused by white matter abnormalities per se. Proponents of this theory suggest that retrograde changes as a result of focal white matter lesions do not satisfactorily explain the extent of the cellular pathology and diffuse nature of grey matter changes (FIG. 3b,c) .
Extensive pathological and imaging evidence supports this argument. For example, several recent studies of grey and white matter demyelination in different regions of the CNS found that the extent of cortical demyelination is greater than that found in white matter 34 . In addition, although cortical demyelination sometimes occurred together with demyelination in the adjacent white matter (leukocortical lesions), in most instances the cortex was affected independently from white matter lesions 35, 36 . Another study observed a gradient of neuronal loss in the precentral gyrus of multiple sclerosis cases that exhibited extensive subpial demyelination, with the greatest loss in the outer cortical layers 17 . There was no relationship between this gradient and the white matter lesion volume or location, which argues strongly against an influence of white matter lesions on grey matter subpial pathology. However, it is likely that extensive primary neuronal loss in the cortical grey matter would lead to anterograde loss of axons in downstream white matter pathways, including the spinal cord.
In addition, extensive and complete subpial demyelination of individual gyri and sulci accompanied by the relative preservation of axons characterizes many cases of secondary progressive multiple sclerosis (SPMS) 12, 37 . This pattern of damage cannot be explained by axonal damage in white matter lesions, which would lead to a more diffuse but incomplete decrease in myelin density due to the loss of individual myelin-axon units. Extensive subpial demyelination was also observed in single biopsies of very early RRMS 38 . In vivo imaging studies confirmed the presence of grey matter lesions during the earliest phases of the disease 39 in patients with very low white matter lesion volume, and sometimes even in patients with radiologically isolated syndrome (before any clinical symptoms are present) 40 , or preceding the occurrence of white matter lesions altogether 41 . However, it should be noted that even when using the most advanced technologies, most grey matter lesions (especially type 3 subpial lesions (FIG. 1c) ) escape identification by MRI, making it difficult to correlate grey matter and white matter damage accurately by this method 42 .
Primary and secondary progressive disease
Phases of multiple sclerosis characterized by a slow progression of disability without a well-defined clinical relapse. These phases usually follow the relapsing-remitting phase (secondary progressive phase) but they can also be in the first phase of the disease (primary progressive multiple sclerosis).
T cell
A lymphocyte that mediates cell-dependent immune responses by providing help (in the form of cytokines, for example) to other immune cells or by cytotoxicity (killing of a virus-infected cell).
Other radiological data suggested that diffuse grey matter atrophy is only partially related to the white matter damage visible by MRI. When brain atrophy was studied in patients with early RRMS, for example, both grey and white matter atrophy were observed, but the correlation between the two was only moderate 43 . A 2-year period of follow-ups of these patients revealed that fluctuations in inflammatory white matter lesions were related to changes in white matter volume rather than to grey matter loss 44 . Voxel-based morphometry and tract-based spatial statistical analyses were applied to assess regional grey matter and white matter damage in 36 RRMS and 25 sex-and age-matched controls 45 . As expected, this analysis revealed significant differences between patients and controls. However, although several measures of white matter damage correlated with each other, none correlated with grey matter volume 45 . More recent imaging studies have found that the relationship between grey matter atrophy and white matter abnormalities was weaker in primary and secondary progressive disease than in RRMS, suggesting that neurodegenerative processes in patients with progressive disease are even less related to white matter changes 46 . These findings could indicate that grey matter damage is either independent of white matter lesions or that white matter is affected in a way that is not detected by currently applied imaging techniques.
Finally, grey matter lesion probability maps and regional analysis of grey matter atrophy revealed a specific topographical distribution of focal and diffuse damage 47 . Most grey matter lesions were found in the frontotemporal lobes, with a particular prevalence in the motor regions. A high probability of focal grey matter demyelination was observed in the hippocampus, deep grey matter and insula 48, 49 , whereas a significant increase in the distribution of diffuse subpial demyelination was observed by means of 7 Tesla MRI in the anterior cingulate cortex 50 . Grey matter demyelination has also been observed in the limbic system and in specific cortical areas such as the mesial temporal lobe 51 . Nevertheless, the spatiotemporal topographical distribution of white matter lesions did not reveal any direct anatomical overlap between areas of significant reductions in grey matter volume and significant increases in focal white matter lesion volume 52 . Does grey matter damage occur as result of or independently of white matter damage? As described above, evidence exists for both. There is little doubt that axonal damage can lead to retrograde loss of neurons. However, this mechanism does not explain the spectrum and extent of grey matter damage in multiple sclerosis, and several studies clearly suggest that the mechanisms of damage within white matter and grey matter may be, at least partly, independent. Furthermore, primary damage to cortical neurons could give rise to anterograde axonal loss, particularly in the spinal cord.
Inflammatory grey matter damage
Although there is limited information on the immune mechanisms that are active in the cortical layer in patients with multiple sclerosis, several causes of inflammatory demyelination within the grey matter can be envisioned (FIG. 4) . These include the possible expression or relative overabundance of a target autoantigen for adaptive (T cell-and antibody-mediated) immune mechanisms 53 or the involvement of a T cell with specificity for both a myelin and neuronal antigen 54 . An alternative hypothesis is that the presence of inflammatory infiltrates in the meningeal space and/or in the adjacent perivascular spaces might lead to the release of cytotoxic inflammatory mediators into the grey matter 17, 38, 55 . This could be caused by an infectious organism located in the adjacent meninges or by a chronic compartmentalized inflammatory response to a self-antigen or self-antigens. Several epidemiological studies have suggested that Epstein-Barr virus (EBV) is one of the strongest candidates for this infectious agent [56] [57] [58] . EBV proteins and RNA have been detected in B cells in the meninges and perivascular spaces of patients with multiple sclerosis with extensive meningeal infiltrates and cortical demyelination [59] [60] [61] . It has been proposed that failure to control latent EBV infection in an immune privileged site, such as the subarachnoid space, could lead ; they are the most common type of grey matter lesion present at autopsy 11 and are the most specific features of multiple sclerosis pathology as they are not seen in any other human inflammatory or neurodegenerative disease. Arrows indicate lesion borders. d | Image of the cingulate gyrus and corpus callosum, illustrating the extensive nature of some subpial lesions. Arrows indicate gyri. In this case, the lesion extends around an entire gyrus and into the next gyrus. Some investigators also define type 4 lesions, which are large, cortex-spanning lesions that do not pass the grey matter-white matter border (not shown).
Lymphocytes that express immunoglobulins as surface receptors or, when they are fully mature following antigenic stimulation, release antibodies that are directed against a virus or bacteria.
to recurrent intrathecal reactivation of EBV and tissue damage in the nearby grey matter 62, 63 . However, several studies were unable to detect EBV in the brain or lesions of patients with multiple sclerosis 64, 65 , and this remains a controversial and highly debated issue 66 . The different results found in these studies are likely to be due to the different types of tissues and multiple sclerosis cases examined, the variable preservation of meningeal tissues in the samples and the differences in the sensitivity of the techniques used to detect EBV infection 67 .
Other viruses, such as torque teno virus, have also been hypothesized to play a part in the pathogenesis of multiple sclerosis because they can infect the CNS 68 , are a target for cerebrospinal fluid (CSF)-infiltrating T cells isolated from patients with multiple sclerosis 69 and interact with EBV 68, 69 . Furthermore, myco-like viruses that are closely related to torque teno virus have recently been isolated from cow milk and the brains of patients with multiple sclerosis, thus providing an interesting link to epidemiological findings on the consumption of cow milk and the geographical prevalence rates of multiple sclerosis 70 . Alternatively, cortical demyelination and neuronal loss could involve an infectious agent with primary tropism for oligodendrocytes and/or cortical neurons 71 , although no evidence exists yet for this possibility in multiple sclerosis.
Other mechanisms that might target adaptive and/ or innate immune responses to the grey matter include alterations specifically linked to the function and/or degeneration of neurons, astrocytes or oligodendrocytes. These alterations might include metabolic changes 72 , excitatory neurotransmitter release 73 , expression of post-translationally modified proteins and/or peptides 74 , changes in electrical activity and/or ion currents, and cytokine and/or cytokine receptor expression 75 . Although none of these possible reasons has yet been proven to be a cause of the topographical distribution of grey matter damage in multiple sclerosis, there are data in support of these ideas, and we therefore believe that they can at least serve as a working hypothesis and basis for further investigation.
Role of parenchymal and perivascular lymphocytes.
A recent study demonstrated that the extent of lymphocyte infiltration in grey matter lesions depends on the disease stage: foamy macrophages, thought to be involved in ongoing demyelination, were found in grey matter active lesions of 66% of patients with early RRMS at biopsy 38 but were rarely found in grey matter lesions from patients with SPMS 37 . The presence of perivascular CD8 + T cells was observed in 77% of intracortical lesions at biopsy with varying frequency depending on the location examined; numbers decreased from leukocortical regions to intracortical lesions and were lowest in subpial lesions 12, 38 . Perivascular T cell and B cell infiltrates have also been observed in both intracortical and subpial lesions in progressive multiple sclerosis cases 55 , particularly in subjects in whom progressive disease with signs of activate inflammation was present at death. The reasons for the heterogeneous distribution of CD8 + T cells in the cortex, their relatively higher frequency in leukocortical and intracortical plaques in comparison to subpial plaques and their localization in perivascular cuffs 38 remain unclear, and further studies are clearly needed.
A wealth of immunological data suggests that CD4 + T cells are inducers and drivers of multiple sclerosis 2 . Key findings that support this notion are, among others, the strong genetic influence of the HLA-DR15 haplotype (see below) 76, 77 , the increased frequency of myelin-specific CD4 + T cells with a pro-inflammatory phenotype in multiple sclerosis 78, 79 and their higher antigen avidity 80 . However, although CD4 + T cells are present in the inflamed meninges above subpial grey matter lesions 17 , little information is available concerning their presence within cortical grey matter lesions. This is surprising if one considers that HLA class II molecules (including HLA-DR alleles) serve as recognition structures for CD4 + T cells and that the HLA-DR15 haplotype is by far the most important genetic risk factor in multiple sclerosis 76, 77 . In fact, a recent study suggested that HLA-DRB1*15 status is associated with the extent of inflammation and demyelination in the motor cortex at autopsy 81 , indirectly suggesting that CD4 + T cells (or an as yet unknown role of HLA class II molecules) are involved in tissue inflammation in the grey matter.
Despite the evidence implicating a role for CD4 + T cells in multiple sclerosis, CD8 + T cells are found at higher frequency than CD4 + T cells in the grey matter and brains of patients with multiple sclerosis at autopsy 38, 82 , and are more frequently clonally expanded 83 , suggesting that CD8 + T cells have proliferated locally in the brain. However, the local proliferation of T cells within the grey matter lesions themselves has not yet been examined, and CD4 + intracerebral T cells have generally been studied to a lesser extent than CD8 + cells. CD8 + T cells are also thought to be more likely to directly damage neurons and other CNS cells than CD4 + T cells because HLA class II molecules are expressed at very low levels and on a limited number of cells in the CNS, whereas HLA class I molecules, which present antigen to CD8 + T cells, show broader expression in multiple sclerosis brains 75 . However, although HLA class II molecules Figure 3 | Is grey matter atrophy a primary or secondary pathological process? An important issue in multiple sclerosis concerns the relationship between grey and white matter damage. In particular, it is unclear whether grey matter damage is secondary to white matter pathology or is a primary pathological process. MRI can be used to study the relationship between white matter lesions and grey matter atrophy. a | MRI images of a patient with relapsing-remitting multiple sclerosis (RRMS) (T1-weighted, fluid-attenuated inversion recovery and double inversion recovery sequences) showing marked demyelination of the optic radiations (arrows) and marked atrophy of the calcarine sulcus (arrowheads) b | MRI images of a patient with RRMS. These show a very low white matter lesion load and a severe cortical atrophy (arrowheads) of the right and left central sulcus (note that the sulcus is enlarged and that the patient has no spinal cord lesions). c | MRI images of a healthy control. Collectively, these images suggest that severe atrophy of a cortical region can be the consequence of severe demyelination of the white matter fibres that originate from that region (as in part a), but it can also be present in the absence of any MRI-visible white matter or grey matter lesion (as in part b). The MRI images were acquired using a 3 Tesla Philips scanner. Images taken by M.C. at the Advanced Neuroimaging Laboratory of Neurology, Radiology Unit BT, University Hospital of Verona, Italy. Nature Reviews | Neuroscience are not expressed by neurons, they are expressed by activated microglia and astrocytes. Proteins and peptides that are released from damaged neurons can be presented by these cells to CD4 + T cells 84 , although this process has not been examined yet in the grey matter of patients with multiple sclerosis. Furthermore, HLA class I molecule expression has been described in electrically silent neurons (those that are functionally compromised or damaged), and data from experimental systems suggest that the exposure of neurons to interferon-γ (IFNγ) renders them immunological targets for CD8 + T cells 75 . In summary, the existing evidence suggests an involvement of both CD4 + and CD8 + T cells in cortical damage in multiple sclerosis, although they may make different contributions to the cortical degeneration. That is, initiation and perpetuation may be driven by CD4 + T cells, whereas effector mechanisms such as direct neuronal and axonal damage are more likely to be caused by CD8 + T cells. Several mechanisms through which CD8 + and CD4 + T cells could damage neurons and oligodendrocytes have been proposed. These include antigen-specific Figure 4 | Immune-mediated mechanisms of subpial cortical demyelination in progressive multiple sclerosis. Schematic depiction of the immunological and pathological events associated with neurodegeneration, oligodendrocyte and astrocyte damage, and increased microglial activation in patients with progressive multiple sclerosis. Inflammatory cells in both meningeal infiltrates (which may be both diffuse and localized in the tertiary lymphoid-like tissue) and intracortical immune infiltrates could either directly or indirectly induce neuronal, axonal and oligodendrocyte damage. Direct damage can be caused via the release of inflammatory mediators (including interferon-γ (IFNγ), type I IFNs, tumour necrosis factor (TNF), other cytokines, chemokines and possibly antibodies) and cytotoxic factors (including matrix metalloproteinases (MMPs), granzymes and perforin). Indirect damage can be caused via intense microglial activation. Although myelin-laden macrophages have been found only in actively demyelinating cortical lesions during early multiple sclerosis, microglial activation is a diffuse event occurring in grey matter lesions and normal-appearing grey matter, and has a central role in grey matter cell injury. Microglia are involved in both the release of inflammatory stimuli (such as TNF, nitric oxide (NO) and myeloperoxidase (MPO)) and also in altered glutamate reuptake, and consequently neuronal and synaptic damage due to excitotoxicity. Astrocyte loss and/or dysfunction may also have a key role in grey matter injury. Astrocyte loss may contribute to glia limitans destruction and therefore favour the diffusion of soluble factors from the subarachnoid space towards inner cortical layers. Furthermore, astrocytes have a fundamental role in maintaining the oligodendrocyte-axonal-synaptic apparatus and in modulating the movement of molecules through the cortex. Microglial activation, astrocyte dysfunction and the potential direct cytotoxic and/or myelinotoxic effects of inflammatory cells may all be involved in oligodendrocyte damage and myelin destruction. Finally, there is accumulating evidence highlighting the important role of mitochondrial dysfunction in axonal loss and in neurodegeneration. 
Experimental autoimmune encephalomyelitis
An animal model of multiple sclerosis that is initiated in animals by injecting myelin proteins or peptides to raise autoreactive T cells or by the transfer of autoreactive T cells into naive recipients.
and antigen-independent mechanisms as well as cell contact-dependent and -independent processes 85 . However, all of the major cytotoxic mechanisms that have been proposed have been described mainly in experimental models. These mechanisms include the release of perforin 86 or granzymes 87 , the involvement of FAS (also known as CD95) and FAS ligand (also known as CD95L) 88 , cell lysis by TRAIL (also known as TNFSF10) 89 , and the induction by IFNγ of neuronspecific, calcium-permeable complexes between the IFNγ receptor and glutamate receptor 1 (REF. 90 ). It is important to note that the ability to kill target cells by perforin-or FAS-FAS-ligand-mediated lysis, which is typically attributed only to CD8 + T cells, has also been shown for human CD4 + T cells 91 . Furthermore, an antigen-independent lysis mechanism that involves CD56 (also known as NCAM), which is expressed on natural killer cells and a subset of CD4 + T cells 92 , has been implicated in the lysis of oligodendrocytes 93 .
Role of meningeal inflammatory infiltrates.
Several neuropathological studies in the past decade have shed light on the association between meningeal inflammation and pathology of the adjacent cerebral cortex, both in multiple sclerosis and in experimental autoimmune encephalomyelitis rodent models 17, 38, [94] [95] [96] [97] [98] . Aberrant tertiary lymphoid-like structures containing large aggregates of CD20 + B cells 17, 37, 94 , which are hallmarks of several other chronic inflammatory diseases, were found in the inflamed meninges of a substantial proportion of SPMS cases that were examined post mortem. Similar accumulations of B cells have been reported in 40% of cortical biopsies from early RRMS cases, in which they are associated with underlying subpial demyelination 38 . The SPMS cases exhibiting lymphoid-like immune cell aggregates were characterized by a high degree of inflammatory activity 17, 37, 94, 99 . The study was carried out on 123 post-mortem multiple sclerosis cases with a wide range of ages at onset, progression and death, and total disease duration, to avoid selection bias 37 . However, an independent smaller study failed to find such lymphoid structures 100 . As previously discussed, this disparity may be a result of differences in the technical approaches used, such as different procedures of tissue processing, cutting and staining, and cohort choice 65, 101 . Organized meningeal infiltrates were present predominantly in multiple sclerosis cases characterized by an earlier age at death and with evidence of ongoing inflammatory activity; such cases are not always present in autopsy collections. In addition to the organised lymphoid-like structures that have been reported, extensive diffuse meningeal infiltrates have been detected at autopsy 100, 102, 103 , which may explain the widespread nature of subpial demyelination. Subpial demyelination and cortical atrophy are more pronounced within deep invaginations of the cortex 16, 17, 35 , suggesting that regional differences in CSF flow and/or stasis may result in a shielded niche (or microenvironment) for the persistence of lymphoid-like structures within cerebral sulci. It can be speculated that this may sustain a local immune response that is particularly enriched in CD20 + B lymphocytes and plasmablasts, but also comprising CD4 + and CD8 + T cells and macrophages. This response may chronically generate inflammatory, cytotoxic and possibly myelinotoxic mediators that, by circulating within the CSF, may diffuse freely throughout the subarachnoid space. These mediators might cross the pial membrane towards the adjacent grey matter and specifically mediate diffuse and focal subpial grey matter injury in multiple sclerosis. The release and circulation of specific, but as yet unknown, factors in the CSF bathing the cerebral cortex could explain the fact that subpial cortical demyelination is one of the most specific features of multiple sclerosis pathology 104 . Among these factors, tumour necrosis factor and IFNγ may play a fundamental role in mediating subpial pathology directly or indirectly by regulating microglial activity. Indeed, the expression of tumour necrosis factor and IFNγ is significantly increased both in the meninges and CSF samples from post-mortem SPMS cases with higher levels of meningeal inflammation and cortical damage 99 . This hypothesis is also corroborated by the finding that a subset of patients with SPMS with higher levels of inflammation and frequency of immune cell infiltrates in the meninges had a higher subpial grey matter lesion volume, a higher degree of neuronal, astrocyte and oligodendrocyte loss, and increased microglial activation 17, 37 . The severity of these parameters followed a gradient from the external cortical layers towards the innermost cortical layers 17, 37 . Interestingly, the subpopulation of SPMS cases with higher levels of meningeal inflammation and grey matter damage were characterized clinically by a more rapidly progressive disease course 17, 37, 94, 105 , although it should be noted that this population of patients clearly represent the more aggressive end of the spectrum of heterogeneous presentations. The link between cortical pathology and a rapidly progressive disease course has also been described in a large proportion of multiple sclerosis cases using non-conventional imaging techniques 39, 105 . Collectively, these results support the idea that increased grey matter pathology, alone or in addition to white matter pathology, may be associated with a more rapid and aggressive disease course from early phases of the disease and that meningeal inflammation may be partly responsible for this increased pathology.
The specific link between meningeal inflammation and severity of grey matter pathology and rapidly progressive disease course is further supported by studies of the spinal cord of post-mortem cases with SPMS 106 , in which the levels of both meningeal T cells and activated parenchymal microglia were associated with increased diffuse axonal loss. Furthermore, a recent study examining a large number of brain biopsies from patients with recently diagnosed multiple sclerosis 38 has indeed revealed that cortical lesions occur early in the disease and are highly inflammatory, and associated with both focal perivascular and diffuse meningeal inflammation. The reported association between meningeal inflammation and immune infiltrates in chronic subpial lesions, either in brain biopsies from patients with early multiple sclerosis 38 or in post-mortem SPMS cases with more aggressive grey matter pathology 94 , indicate that both meningeal and intraparenchymal grey matter inflammation may have a role in disease pathogenesis. They may have this effect either by causing cortical damage at the beginning of the disease and/or by exacerbating grey matter pathology as disease progresses.
Role of microglia. Microglia are innate immune cells that are resident in the CNS and are considered to be the dominant effector cell population in cortical grey matter injury 12 . Elongated microglia that are oriented perpendicularly to the pial surface and are closely apposed to apical dendrites and axons, together with activated stellate microglia that extend processes to neuronal perikarya, dendrites and axons, are observed in active and chronic grey matter lesions 107 . The number of activated microglia and the degree of activation correlate with the density of transected neurites in grey matter lesions 12 , suggesting that dendrites and axons are vulnerable to microglial activation 107 . Microglial activation could also be a consequence of neuronal and axonal damage and thus a sign of prior injury 108 . However, in post-mortem multiple sclerosis brain tissue, the number of microglia in cortical lesions also correlates with the degree of meningeal immune cell infiltration 37 . Therefore, it is unclear whether microglia have a neuroprotective or detrimental role within the cortex in multiple sclerosis, and what the sequence of events is.
In the mature brain, microglia typically exist in a resting state and continually survey the microenvironment with their motile processes and protrusions 109 . Bloodbrain barrier disruption, brain injury or immunological stimuli provoke immediate and focal activation of microglia 110 . Depending on the circumstances of activation, microglia may differentiate into a type 1 phenotype, which can be pro-inflammatory and detrimental, or a type 2 phenotype, which is immunomodulatory, supports survival and provides an antioxidant defence 111 . However, the phenotype of activated microglia in cortical multiple sclerosis lesions has yet to be determined. For microglia to remain in a chronic state of activation in the multiple sclerosis cortex, there would need to be a chronic stimulus. It can be hypothesized that the presence of a chronically inflammatory milieu in the subarachnoid 99 and perivascular spaces 61 might represent such a stimulus. Other stimuli that promote microglial over-activation and dysregulation include environmental toxins and neuronal death or damage. However, the conditions that determine whether microglial activation is detrimental or beneficial to neuronal survival are currently poorly understood in multiple sclerosis.
Nevertheless, it is becoming more widely accepted that microglial activation is necessary and crucial for host defence and neuronal survival, whereas their over-activation may be deleterious to neurons and oligodendrocytes 112 . In post-mortem homogenates of demyelinated and non-demyelinated cerebral cortical regions from multiple sclerosis cases, grey matter demyeli nation has been shown to be associated with increased activity of myeloperoxidase 113 . Myeloperoxidase is expressed by a CD68 + subset of activated microglia found in active grey matter demyelination towards the edge of the lesions but not by microglia in adjacent non-demyelinated cortex 113 . Moreover, the presence of activated microglia in grey matter lesions in patients with multiple sclerosis has been correlated with focal loss of the glutamate transporters excitatory amino acid transporter 1 (EAAT1) and EAAT2, and synaptophysin immunostaining 114 , suggesting that activated microglia may also perturb astrocyte function and glutamate metabolism. Alterations in the mechanisms of glutamate reuptake found in grey matter lesions in the presence of activated microglia could be associated with signs of neuronal and synaptic damage suggestive of excitotoxicity 114 (see below). Furthermore, an increase in microglial activity together with neuronal and axonal loss has been found in the subpial cortex of patients with SPMS with increased diffuse and organised meningeal inflammation 37, 94 . Increased numbers of activated CD68 + microglia have also been observed in active and/or chronic cortical lesions of patients with primary progressive multiple sclerosis at autopsy 103 . Moreover, activated microglia are found along the border of grey matter lesions in a large proportion of patients with multiple sclerosis with extensive subpial demyelination 115 . These patients were younger at the time of death than patients without grey matter lesions or patients without rims of activated microglia in grey matter lesions 100 .
Non-inflammatory neurodegeneration?
A recent theory highlighted the inconsistencies in the inflammatory model described above and proposed a degenerative model as the primary cause of multiple sclerosis. In the degenerative model, a primary 'cytodegeneration' that is initially focused on oligodendrocytes and/or neurons begins years before any clinical symptoms appear. The autoimmune inflammatory reaction that is later observed would depend on the host's predilection to react to the antigens released as a consequence of the cellular degeneration. This hypothesis arose as a result of inconsistencies in the literature, including observations of early myelin protein degradation before the prototypical adaptive immune response and the inability to stop disease progression using potent antiinflammatory drugs [116] [117] [118] . However, although this hypothesis seems plausible, other interpretations are more likely. For example, adaptive immune processes that initiate white matter and grey matter damage may later -when demyelination and indirect injury to axons as well as direct axonal transections have reached a critical level -lead to ongoing neurodegeneration that progresses independently of new inflammation. Alternatively, the efficacy of current immunomodulatory therapies may decrease as the immune response that drives multiple sclerosis pathology becomes increasingly compartmentalized within the CNS or CSF. According to this hypothesis, ongoing inflammation would require less infiltration of cells from the peripheral immune system and therefore might not respond to systemically delivered therapies that primarily act as immunomodulators in the peripheral immune system. It is likely, as has been suggested previously 116 , that multiple sclerosis involves both inside-out and outside-in disease mechanisms, jointly contributing to its variable course. However, large genomewide association studies support a primary role of immune system alterations because the vast majority of the more than 100 common genetic variants 119 that have been identified so far are immune-related.
Conclusions and perspectives
The evidence reviewed above suggests that damage to the grey matter in multiple sclerosis proceeds in a manner that is partly independent of white matter damage, although there is clearly some degree of relationship between the two types of damage
. This relative independence is illustrated by the fact that some cases of multiple sclerosis exhibit predominantly grey matter pathology with little white matter involvement, and vice versa. Neuronal degeneration inevitably follows axonal transection in white matter lesions and leads to a variable and dispersed loss of neurons in grey matter areas related to the anatomical location of the white matter lesions. Neuronal loss in the grey matter -as a result of inflammatory processes or more intrinsic mechanisms of degeneration (such as a local energy deficit due to mitochondrial dysfunction)
-also leads to axon loss and degeneration of downstream neurons. Whether grey matter damage may, at some point in the disease, proceed owing to a primary degenerative process independent of inflammation and independent of white matter damage remains to be resolved. Currently, there is no evidence of a primary trigger similar to that seen in other neurodegenerative conditions. Evidence exists for a role of inflammatory processes, both innate in the parenchyma and adaptive in the meninges and perivascular spaces, alongside a role for degenerative processes involving mitochondrial dysfunction and energy deficits. However, these different processes have yet to be conclusively linked. Studies of the very early stages of the disease are required to clarify whether inflammation and/or immune mechanisms or neurodegeneration is the primary cause of the disease. Nevertheless, it is apparent that at some point both mechanisms are simultaneously active in grey matter and white matter in multiple sclerosis.
To complicate matters further, the relationship between white and grey matter damage may differ across brain regions, disease phases and multiple sclerosis phenotypes. Additional longitudinal studies that focus on the very early stages of the disease, when either the white matter or the grey matter are almost intact, are required to clarify the relationship between white and grey matter damage. As such studies are unlikely to be possible using post-mortem or biopsy tissue samples, the most promising approaches will be combinations of ever more sophisticated imaging methods such as MRI, spectroscopy and positron-emission tomography imaging with immunological, proteomics and metabolomics methods using CSF.
In light of accumulating evidence indicating that patients with multiple sclerosis with similar white matter lesion volumes undergo a more severe clinical course in the presence of higher and more diffuse grey matter Infectious agents and compartmentalized immune responses. It is proposed that an infectious organism located in the adjacent meninges or an infectious agent with primary tropism for cortical neurons and/or oligodendrocytes may result in the formation of aberrant tertiary lymphoid-like structures within the meninges or the cortical layer. These tertiary lymphoid-like structures may induce a chronic compartmentalized inflammatory response against neurons or oligodendrocytes that is characterized by the presence of CD4 + and CD8 + T cells and CD20 + B cells and plasmablasts.
CNS innate inflammatory mechanisms
Chronic microglial activation. The presence of a chronic inflammation in the subarachnoid and perivascular spaces, environmental factors such as toxins, or neuronal damage or death, might cause an abnormal and chronic microglial over-activation that can be directly harmful to neurons. This aberrant microglial activation may also lead to a dysregulation of astrocyte functions and glutamate metabolism, resulting in further neuronal and synaptic damage.
Non-inflammatory neurodegenerative mechanisms
Primary neurodegeneration. A primary neurodegenerative event involving neurons, astrocytes or oligodendrocytes that may be caused or worsened by mitochondrial injury. Metabolic compromise may explain the substantial neuronal injury accompanied by relatively minor parenchymal inflammation, microglial activation and associated meningeal inflammation, which are usually observed in multiple sclerosis.
Retrograde degeneration due to white matter damage. Reduction of cortical grey matter volume and thinning may be the consequence of white matter pathology via retrograde degeneration, especially in the more advanced disease phase, thus explaining the significant neuronal loss observed even in the non-demyelinated cortex.
Box 2 | The role of mitochondrial injury in grey matter damage
Mitochondrial injury is found in lesions characterized by all of the typical pathological features of multiple sclerosis, including inflammation, demyelination, oligodendrocyte apoptosis and axon degeneration 119 . A role for inflammation in mitochondrial dysfunction is suggested by post-mortem studies showing that reactive oxygen species produced by activated microglia and macrophages can induce mitochondrial dysfunction in both white matter 120 and grey matter lesions 104 . Several lines of evidence have led to the hypothesis that mitochondrial injury is a primary phenomenon in multiple sclerosis 121 . Neurons deficient in components of the respiratory chain have been identified in normal-appearing brain tissue and are distributed diffusely in the cortex of patients with multiple sclerosis 122 . Focal intra-axonal mitochondrial pathology is also one of the earliest signs of damage in a mouse model of multiple sclerosis 123 . Abnormal mitochondrial gene expression and impaired activity of the mitochondrial respiratory chain complexes I and III, which can be found in demyelinated cortex samples of patients with progressive multiple sclerosis 124 , may result in mitochondrial dysfunction and a state of impaired energy production. Finally, a characteristic hypoxia-like injury caused by mitochondrial impairment might also be involved in neurodegeneration in multiple sclerosis lesions 125, 126 . Irrespective of the initial event, the presence of a local energy deficit in grey matter may induce a vicious cycle that leads to an increased mitochondrial production of reactive oxygen species and further deletions of mitochondrial DNA 127 . Energy-deficient neurons may be more prone to inflammatory insult, which induces increased energy demand in the presence of a reduced energy supply 128 . Although the precise causes of neuronal respiratory deficiency in multiple sclerosis are still unclear, the neuronal energy deficit is crucial for inducing axonal swelling and subsequent neuronal death, especially when it occurs as a consequence of inflammation, as is the case in grey matter regions in patients with multiple sclerosis. lesion volumes and atrophy already from the early disease phases, it may be suggested that cortical pathology has a key role in determining the rate of disability progression in multiple sclerosis. As with other progressive neurodegenerative conditions, it is likely that the accumulation of disability is directly related to increasing loss of vital neuronal populations, and the rate at which they are lost and their locations determine the relative rate of disease progression. However, in contrast to other neurodegenerative conditions, the loss of neurons and axons is much more diffuse, which is reflected in the heterogeneous decline in diverse motor, sensory and cognitive functions. Knowledge of the mechanisms underlying grey matter damage and identification of measures of disease progression associated with cortical pathology could help to identify prognostic biomarkers and individualized therapies with increased efficacy for patients with a predisposition to develop more severe cortical pathology and associated clinical deterioration. Whether this predisposition is linked to genetic, environmental or other factors and is common to white matter immunopathogenesis remains unknown and highlights the need for more detailed studies. Despite the unknowns, from a therapeutic point of view, a combination of immunomodulatory and neuroprotective strategies appears to be the most promising to limit both grey matter degeneration and development of long-term disability.
